01
Human Genetic Background
Donor-derived cells retain genetic information that can help investigate inherited disease-associated mechanisms.
Stem Cell Science / Human Disease Research
Disease Modeling with Stem Cells & iPSCs
Discover how patient-derived stem cells, induced pluripotent stem cells, engineered cellular models and organoids support the investigation of human disease mechanisms, genetic variation and experimental drug responses.
01 / Scientific Foundations
Understanding Stem Cell Disease Modeling
Stem cell disease modeling uses living cellular systems to investigate selected biological characteristics associated with human disorders.
Researchers can study disease-related processes in cells that retain relevant donor genetic information or contain experimentally engineered genetic changes. When induced pluripotent stem cells are differentiated toward a target lineage, they can provide access to human cell types that may otherwise be difficult to obtain.
These models are especially useful for examining cellular mechanisms, comparing genotypes and identifying potential responses to experimental interventions. However, no individual cell model captures the complete complexity of human disease.
02
Relevant Cell Types
Differentiation enables the study of specialized cells affected by particular diseases or genetic variants.
03
Experimental Comparisons
Disease-associated and control populations can be analyzed for molecular or functional differences.
04
Mechanistic Investigation
Researchers examine cellular pathways that may contribute to observed disease phenotypes.
02 / Patient-Derived Models
How Patient-Derived iPSCs Support Research
Patient-derived iPSCs make it possible to investigate disease-associated genetic backgrounds in experimental populations of differentiated human cells.
Reprogramming allows suitable donor cells to acquire pluripotent characteristics. Researchers can then characterize the resulting iPSC lines and investigate selected disease-relevant lineages.
A major advantage is access to cellular material representing specific genetic backgrounds. The limitations include differences between donors, variation introduced during reprogramming, and incomplete maturation of differentiated cells.
STAGE 01
Donor Material
Document cell origin, consent and relevant genetic information.
STAGE 02
Reprogramming
Establish candidate induced pluripotent cell populations.
STAGE 03
Characterization
Assess identity, genomic integrity and pluripotency.
STAGE 04
Cell Differentiation
Investigate the relevant disease-associated lineage.
STAGE 05
Phenotype Analysis
Evaluate molecular and functional disease features.
Important distinction
Donor-derived iPSC models preserve much of the donor's genetic background but do not necessarily preserve age-related or acquired cellular characteristics after reprogramming. This can limit modeling of late-onset disorders.
03 / Disease Applications
Major Disease Areas Investigated with iPSCs
Human stem cell-derived models can represent different tissues and biological systems, offering experimental approaches to investigate selected disease mechanisms.
01
Neurological Disorders
Neuronal and glial models help investigate selected mechanisms associated with neurodevelopmental and neurodegenerative disorders.
02
Cardiovascular Disease
iPSC-derived cardiomyocytes support investigation of inherited arrhythmias and other cardiac phenotypes.
03
Metabolic Disorders
Specialized liver and pancreatic models can help investigate selected cellular metabolic abnormalities.
04
Inherited Retinal Disease
Retinal cell and organoid models offer systems to investigate disease-associated photoreceptor abnormalities.
05
Muscular Disorders
Stem cell-derived muscle populations support research into selected genetic abnormalities affecting muscle.
06
Rare Genetic Diseases
Patient-specific cell models enable investigation of biological consequences of uncommon genetic variants.
04 / Genetic Controls
Understanding Isogenic Cell Models
Isogenic models are cell populations designed to share a closely matched genetic background while differing at a defined genetic locus or modification.
Such comparisons can help researchers investigate whether a selected genetic variant contributes to a measurable phenotype. For example, correction of a disease-associated variant in a patient-derived line may support a causal interpretation if the relevant phenotype changes.
Genome editing and clone selection can introduce additional genetic differences, so independent clones, genetic assessment and complementary control strategies remain important.
| Control Strategy | Main Advantage | Main Limitation |
|---|---|---|
| Unrelated control donors | Represent wider biological diversity. | Genetic backgrounds may confound comparisons. |
| Family-related controls | May reduce some background genetic variation. | Relatives still differ genetically and biologically. |
| Gene-corrected isogenic controls | Permit comparison of a selected disease-associated variant. | Editing-associated changes and clone effects require assessment. |
| Engineered disease variants | Support focused investigation of a genetic alteration. | May not reproduce the full patient genetic background. |
Genetic matching strengthens experimental interpretation.
Isogenic comparisons can help distinguish the effects of a candidate mutation from unrelated genetic variability. They do not eliminate the need for independent replication or careful assessment of genomic integrity.
05 / Biological Phenotyping
Identifying Disease-Associated Cellular Phenotypes
A disease phenotype is an observable cellular or molecular characteristic associated with a disease state, genetic variant or experimental condition.
Relevant phenotypes differ between disorders. They may involve altered electrophysiology, protein localization, cell morphology, metabolic activity, gene expression or cellular survival.
Assays must distinguish disease-relevant effects from differences caused by cell maturity, experimental stress, culture conditions or unrelated biological variability.
Gene Expression
Transcriptomic studies can identify patterns associated with altered cell state or disease-related pathways.
Protein Characterization
Immunological and proteomic approaches help assess disease-associated protein abundance or localization.
Cellular Morphology
Imaging can reveal relevant structural changes including cell shape, organization or cellular connectivity.
Electrophysiology
Neuronal and cardiac models may be characterized through electrical activity and ion channel function.
Metabolic Function
Biochemical assays can investigate alterations in energy metabolism and selected cellular pathways.
Cell Survival
Changes in viability, proliferation or stress responses can provide disease-relevant information.
06 / Advanced Cell Systems
Organoids and Multicellular Disease Models
Complex diseases frequently involve interactions among multiple cell populations, making single-cell-type models insufficient for certain questions.
Organoids, co-cultures and microphysiological systems can incorporate selected tissue interactions and structural features. These systems offer additional biological complexity but introduce challenges in cell composition, maturation and experimental reproducibility.
01
Organoid Models
Three-dimensional structures reproduce selected tissue-level organization and cell interactions.
02
Co-Culture Systems
Multiple cell populations can be studied together to investigate interactions between relevant lineages.
03
Organ-on-Chip Models
Engineered systems may reproduce flow conditions, mechanical cues and selected tissue interfaces.
04
Engineered Tissue Models
Structured cellular systems allow researchers to investigate selected interactions between cells and their environment.
Model selection principle
Greater model complexity is not automatically better. A simpler cellular model may be more suitable when the research question concerns a specific cell-autonomous mechanism.
07 / Drug Discovery
Using Human Cell Models to Study Drug Responses
Stem cell-derived disease models can support early-stage investigations of compound activity and disease-associated cellular responses.
Researchers may examine whether a candidate compound changes a defined disease phenotype. Measurements can involve cellular function, molecular signaling, morphology or survival.
Such experiments provide mechanistic evidence and may help prioritize compounds for further evaluation. They do not establish clinical efficacy or safety in patients.
Phenotypic Screening
Assesses cellular responses using measurable biological characteristics relevant to the experimental model.
Target Investigation
Explores the contribution of selected molecular targets or pathways to a disease-related phenotype.
Toxicity Research
Examines selected harmful cellular effects in relevant differentiated human cell populations.
Response Variability
Compares experimental responses across different donor-derived backgrounds or cellular models.
08 / Quality & Validation
How to Evaluate a Disease Model
Reliable disease models require evidence that the experimental system represents the intended cell type and reproduces a relevant biological phenotype.
Genotype Confirmation
Confirm that experimental cells contain the expected genetic variant or engineered alteration.
Cell Identity
Establish the target-cell lineage using suitable marker panels and functional characteristics.
Biological Relevance
Compare disease-associated features with appropriate clinical or biological reference information.
Independent Replication
Evaluate consistency across independent cell lines, clones and experimental preparations where feasible.
Appropriate Controls
Use a control strategy that addresses the intended disease mechanism and possible confounders.
Statistical Interpretation
Consider biological replicate structure, variability, sample size and meaningful effect sizes.
Scientific best practice
The ISSCR emphasizes validating cell identity, expected genotype, disease-relevant functional properties and appropriate independent controls.
09 / Limitations & Future Directions
What Stem Cell Disease Models Cannot Yet Reproduce
Stem cell technologies have transformed human disease research, but important challenges remain in biological maturity, systemic complexity and the interpretation of patient-specific results.
Cellular Maturity
Derived cells may retain immature developmental characteristics that limit their resemblance to adult tissues.
Complex Tissue Interactions
Isolated cultures may lack immune, vascular, endocrine and other systemic influences.
Donor Variability
Genetic background and biological differences complicate comparisons between independent donors.
Experimental Variability
Differences between batches, differentiation conditions and assays may affect measured phenotypes.
Late-Onset Disease
Reprogramming-associated resetting of some age-related characteristics can complicate late-onset disease studies.
Clinical Translation
Disease-related cellular responses do not automatically predict clinical outcomes or treatment benefit.
Scientific progress requires model validation.
Improved cell maturation, multi-lineage models, single-cell analysis and better experimental standardization may increase the usefulness of stem cell disease models. Their value will continue to depend on evidence that measured features correspond to the intended biological processes.
10 / Related Research
Explore Further Scientific Resources
Connect disease modeling with the fundamental technologies and laboratory resources used to develop human cell models.
iPSC Technology
Explore cellular reprogramming, pluripotency and the characterization of iPSC lines.
Explore iPSCs →Cell Differentiation
Learn about lineage specification, maturation and cell identity validation.
Explore differentiation →Organoids & 3D Models
Understand three-dimensional tissue models and their applications in disease research.
Explore organoids →Scientific References
- Takahashi K et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. Read publication
- International Society for Stem Cell Research. Standards for Human Stem Cell Use in Research: Stem Cell-Based Model Systems. View research standards
- International Society for Stem Cell Research. Basic Stem Cell Research Standards: Overview and Reporting Recommendations. View research standards
- Clevers H. (2016). Modeling Development and Disease with Organoids. Cell. Read publication
Scientific and ethical scope
This resource is intended for scientific education. The use of patient-derived biological material requires suitable consent, ethical oversight and protection of donor data. Cellular models do not establish clinical diagnosis or treatment effectiveness.